This compound is a quinazoline derivative used as an intermediate in pharmaceutical manufacturing. Its structure features a bromo-fluoro-substituted aniline group attached to a methoxyquinazolinol core.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 196603-96-0
3-Amino-4-chlorobenzamide
pharmaceutical intermediate
(R)-alpha-Amino-3-pyridinepropanoic acid methyl ester dihydrochloride
pharmaceutical intermediate
4-(3-Piperidyl)aniline Dihydrochloride
pharmaceutical intermediate
Dolutegravir impurity 3
pharmaceutical intermediate
Neptinib
pharmaceutical raw material
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-hydroxyquinazolin-6-yl)-4-(dimethylamino)but-2-enamide
pharmaceutical raw material
6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol
pharmaceutical intermediate
Erlotinib hydrochloride
pharmaceutical raw material
4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-ol
XIHOMGRMQWNHHB-UHFFFAOYSA-N
COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C=C(C=C3)Br)F)O
—